Report Detail
Global Hemostasis and Tissue Sealing Agents Market Growth 2019-2024
- RnM2975270 |
- 18 February, 2019 |
- Global |
- 167 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Hemostasis is a process which causes bleeding to stop, meaning to keep blood within a damaged blood vessel (the opposite of hemostasis is hemorrhage). It is the first stage of wound healing.
Tissue sealing agents are used during medical procedures to achieve hemostasis. They vary based on their mechanism of action, composition, ease of application, adherence to tissue, immunogenicity and cost. These agents permit rapid hemostasis, better Visualization of the surgical area, shorter operative times, decreased requirement for transfusions, decreased wound healing time and overall improvement in patient recovery time.
The classification of Hemostasis and Tissue Sealing Agents includes Hemostasis and Tissue Sealing Agents and the revenue proportion of Hemostasis Agent in 2017 is about 64%
North America is the largest consumption place, with a consumption market share nearly 42% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
According to this study, over the next five years the Hemostasis and Tissue Sealing Agents market will register a 6.0% CAGR in terms of revenue, the global market size will reach US$ 3990 million by 2024, from US$ 2810 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Hemostasis and Tissue Sealing Agents business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Hemostasis and Tissue Sealing Agents market by product type, application, key manufacturers and key regions and countries.
This study considers the Hemostasis and Tissue Sealing Agents value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Hemostasis Agents
Tissue Sealing Agents
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Minimally Invasive Surgery
General Surgery
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Johnson & Johnson
Baxter
C R Bard
B Braun
Gelita
Integra Life Sciences
Advance Medical Solution
Pfizer
CSL Behring
CryoLife
Zimmer Biomet
Ferrosan Medical Devices
Medtronic
Smith & Nephew
Z-Medica
Equimedical
Marine Polymer
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Hemostasis and Tissue Sealing Agents consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Hemostasis and Tissue Sealing Agents market by identifying its various subsegments.
Focuses on the key global Hemostasis and Tissue Sealing Agents manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Hemostasis and Tissue Sealing Agents with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Hemostasis and Tissue Sealing Agents submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Hemostasis and Tissue Sealing Agents Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Hemostasis and Tissue Sealing Agents Consumption 2014-2024
- 2.1.2 Hemostasis and Tissue Sealing Agents Consumption CAGR by Region
- 2.2 Hemostasis and Tissue Sealing Agents Segment by Type
- 2.2.1 Hemostasis Agents
- 2.2.2 Tissue Sealing Agents
- 2.3 Hemostasis and Tissue Sealing Agents Consumption by Type
- 2.3.1 Global Hemostasis and Tissue Sealing Agents Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Hemostasis and Tissue Sealing Agents Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Hemostasis and Tissue Sealing Agents Sale Price by Type (2014-2019)
- 2.4 Hemostasis and Tissue Sealing Agents Segment by Application
- 2.4.1 Minimally Invasive Surgery
- 2.4.2 General Surgery
- 2.4.3 Other
- 2.5 Hemostasis and Tissue Sealing Agents Consumption by Application
- 2.5.1 Global Hemostasis and Tissue Sealing Agents Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Hemostasis and Tissue Sealing Agents Value and Market Share by Application (2014-2019)
- 2.5.3 Global Hemostasis and Tissue Sealing Agents Sale Price by Application (2014-2019)
3 Global Hemostasis and Tissue Sealing Agents by Players
- 3.1 Global Hemostasis and Tissue Sealing Agents Sales Market Share by Players
- 3.1.1 Global Hemostasis and Tissue Sealing Agents Sales by Players (2017-2019)
- 3.1.2 Global Hemostasis and Tissue Sealing Agents Sales Market Share by Players (2017-2019)
- 3.2 Global Hemostasis and Tissue Sealing Agents Revenue Market Share by Players
- 3.2.1 Global Hemostasis and Tissue Sealing Agents Revenue by Players (2017-2019)
- 3.2.2 Global Hemostasis and Tissue Sealing Agents Revenue Market Share by Players (2017-2019)
- 3.3 Global Hemostasis and Tissue Sealing Agents Sale Price by Players
- 3.4 Global Hemostasis and Tissue Sealing Agents Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Hemostasis and Tissue Sealing Agents Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Hemostasis and Tissue Sealing Agents Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Hemostasis and Tissue Sealing Agents by Regions
- 4.1 Hemostasis and Tissue Sealing Agents by Regions
- 4.1.1 Global Hemostasis and Tissue Sealing Agents Consumption by Regions
- 4.1.2 Global Hemostasis and Tissue Sealing Agents Value by Regions
- 4.2 Americas Hemostasis and Tissue Sealing Agents Consumption Growth
- 4.3 APAC Hemostasis and Tissue Sealing Agents Consumption Growth
- 4.4 Europe Hemostasis and Tissue Sealing Agents Consumption Growth
- 4.5 Middle East & Africa Hemostasis and Tissue Sealing Agents Consumption Growth
5 Americas
- 5.1 Americas Hemostasis and Tissue Sealing Agents Consumption by Countries
- 5.1.1 Americas Hemostasis and Tissue Sealing Agents Consumption by Countries (2014-2019)
- 5.1.2 Americas Hemostasis and Tissue Sealing Agents Value by Countries (2014-2019)
- 5.2 Americas Hemostasis and Tissue Sealing Agents Consumption by Type
- 5.3 Americas Hemostasis and Tissue Sealing Agents Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Hemostasis and Tissue Sealing Agents Consumption by Countries
- 6.1.1 APAC Hemostasis and Tissue Sealing Agents Consumption by Countries (2014-2019)
- 6.1.2 APAC Hemostasis and Tissue Sealing Agents Value by Countries (2014-2019)
- 6.2 APAC Hemostasis and Tissue Sealing Agents Consumption by Type
- 6.3 APAC Hemostasis and Tissue Sealing Agents Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Hemostasis and Tissue Sealing Agents by Countries
- 7.1.1 Europe Hemostasis and Tissue Sealing Agents Consumption by Countries (2014-2019)
- 7.1.2 Europe Hemostasis and Tissue Sealing Agents Value by Countries (2014-2019)
- 7.2 Europe Hemostasis and Tissue Sealing Agents Consumption by Type
- 7.3 Europe Hemostasis and Tissue Sealing Agents Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Hemostasis and Tissue Sealing Agents by Countries
- 8.1.1 Middle East & Africa Hemostasis and Tissue Sealing Agents Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Hemostasis and Tissue Sealing Agents Value by Countries (2014-2019)
- 8.2 Middle East & Africa Hemostasis and Tissue Sealing Agents Consumption by Type
- 8.3 Middle East & Africa Hemostasis and Tissue Sealing Agents Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Hemostasis and Tissue Sealing Agents Distributors
- 10.3 Hemostasis and Tissue Sealing Agents Customer
11 Global Hemostasis and Tissue Sealing Agents Market Forecast
- 11.1 Global Hemostasis and Tissue Sealing Agents Consumption Forecast (2019-2024)
- 11.2 Global Hemostasis and Tissue Sealing Agents Forecast by Regions
- 11.2.1 Global Hemostasis and Tissue Sealing Agents Forecast by Regions (2019-2024)
- 11.2.2 Global Hemostasis and Tissue Sealing Agents Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Hemostasis and Tissue Sealing Agents Forecast by Type
- 11.8 Global Hemostasis and Tissue Sealing Agents Forecast by Application
12 Key Players Analysis
- 12.1 Johnson & Johnson
- 12.1.1 Company Details
- 12.1.2 Hemostasis and Tissue Sealing Agents Product Offered
- 12.1.3 Johnson & Johnson Hemostasis and Tissue Sealing Agents Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Johnson & Johnson News
- 12.2 Baxter
- 12.2.1 Company Details
- 12.2.2 Hemostasis and Tissue Sealing Agents Product Offered
- 12.2.3 Baxter Hemostasis and Tissue Sealing Agents Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Baxter News
- 12.3 C R Bard
- 12.3.1 Company Details
- 12.3.2 Hemostasis and Tissue Sealing Agents Product Offered
- 12.3.3 C R Bard Hemostasis and Tissue Sealing Agents Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 C R Bard News
- 12.4 B Braun
- 12.4.1 Company Details
- 12.4.2 Hemostasis and Tissue Sealing Agents Product Offered
- 12.4.3 B Braun Hemostasis and Tissue Sealing Agents Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 B Braun News
- 12.5 Gelita
- 12.5.1 Company Details
- 12.5.2 Hemostasis and Tissue Sealing Agents Product Offered
- 12.5.3 Gelita Hemostasis and Tissue Sealing Agents Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Gelita News
- 12.6 Integra Life Sciences
- 12.6.1 Company Details
- 12.6.2 Hemostasis and Tissue Sealing Agents Product Offered
- 12.6.3 Integra Life Sciences Hemostasis and Tissue Sealing Agents Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Integra Life Sciences News
- 12.7 Advance Medical Solution
- 12.7.1 Company Details
- 12.7.2 Hemostasis and Tissue Sealing Agents Product Offered
- 12.7.3 Advance Medical Solution Hemostasis and Tissue Sealing Agents Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Advance Medical Solution News
- 12.8 Pfizer
- 12.8.1 Company Details
- 12.8.2 Hemostasis and Tissue Sealing Agents Product Offered
- 12.8.3 Pfizer Hemostasis and Tissue Sealing Agents Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Pfizer News
- 12.9 CSL Behring
- 12.9.1 Company Details
- 12.9.2 Hemostasis and Tissue Sealing Agents Product Offered
- 12.9.3 CSL Behring Hemostasis and Tissue Sealing Agents Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 CSL Behring News
- 12.10 CryoLife
- 12.10.1 Company Details
- 12.10.2 Hemostasis and Tissue Sealing Agents Product Offered
- 12.10.3 CryoLife Hemostasis and Tissue Sealing Agents Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 CryoLife News
- 12.11 Zimmer Biomet
- 12.12 Ferrosan Medical Devices
- 12.13 Medtronic
- 12.14 Smith & Nephew
- 12.15 Z-Medica
- 12.16 Equimedical
- 12.17 Marine Polymer
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Hemostasis and Tissue Sealing Agents . Industry analysis & Market Report on Hemostasis and Tissue Sealing Agents is a syndicated market report, published as Global Hemostasis and Tissue Sealing Agents Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Hemostasis and Tissue Sealing Agents market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
